EdgarLookup

RECURSION PHARMACEUTICALS, INC.

RXRX NASDAQ CIK: 0001601830 Biological Products, (No Diagnostic Substances) Inc. in DE
View on SEC.gov →
Overview All Filings Annual Quarterly Insiders

Recent Filings

All 882 filings →
Form Description Date
SCHEDULE 13G/A — Mar 27, 2026
8-K 8-K Mar 25, 2026
4 FORM 4 Mar 25, 2026
144 — Mar 23, 2026
4 FORM 4 Mar 18, 2026
144 — Mar 17, 2026
4 FORM 4 Mar 11, 2026
4 FORM 4 Mar 11, 2026
144 — Mar 9, 2026
4 FORM 4 Mar 4, 2026

Insider Transactions

View all →
Insider Title Type Shares Owns After Date
Taylor Ben R Chief Financial Officer Sale 21,383 @ $4.18 761,550 Dec 29, 2025
Khan Najat Chief R&D Commercial Officer Sale 124,403 @ $4.41 611,135 Dec 22, 2025
Gibson Christopher Chief Executive Officer Sale 40,000 @ $4.63 933,839 Dec 4, 2025
Borgeson Blake — Sale 220,000 @ $4.37 6,869,863 Dec 2, 2025
Khan Najat Chief R&D Commercial Officer Award / Grant 84,925 753,122 Nov 5, 2025
Gibson Christopher Chief Executive Officer Sale 100,000 @ $5.70 954,229 Oct 23, 2025
Gibson Christopher Chief Executive Officer Sale 100,000 @ $6.04 974,229 Oct 10, 2025
Li Dean Y — Award / Grant 1,961 1,238,528 Oct 1, 2025
Dar Zavain — Award / Grant 2,941 138,758 Oct 1, 2025
Gibson Christopher Chief Executive Officer Sale 100,000 @ $4.76 954,229 Sep 25, 2025